ASX:BDA

Bod Australia (BDA) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
75,095 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Bod Australia

Bod Australia Limited operates as a cannabis centric healthcare company in Australia, the United Kingdom, and internationally. The company operates through three segments: Medical, OTC CBD/Hemp, and OTC Herbals. It offers medicinal cannabis, cannabidiol (CBD), and hemp healthcare products. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.

BDA Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
UK logs another SEVENTY-SEVEN monkeypox cases
Will Bod Australia (ASX:BOD) Spend Its Cash Wisely?
BOD Australia Ltd (BDA)
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
See More Headlines
Receive BDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bod Australia and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Today
4/23/2024

Industry, Sector and Symbol

Industry
Household & Personal Products
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.42 million
Book Value
A$0.08 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Joanne Patterson
    CEO, Exec. Director & Member of Medical Advisory Board
  • Mr. Craig Weller
    COO & Member of Medical Advisory Board
  • Mr. Alan Dworkin
    Chief Financial Officer
  • Dr. Adele Hosseini
    Chief Scientific Officer & Member of Medical Advisory Board
  • Mr. Stephen Kelly
    Company Sec.

BDA Stock Analysis - Frequently Asked Questions

How were Bod Australia's earnings last quarter?

Bod Australia Limited (ASX:BDA) posted its earnings results on Thursday, February, 28th. The company reported ($0.05) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Bod Australia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bod Australia investors own include Syrah Resources (SYR), Argent BioPharma (MXC), Medlab Clinical (MDC), Lynas Rare Earths (LYC), iSignthis (ISX), Eclipx Group (ECX), Botanix Pharmaceuticals (BOT) and AusCann Group (AC8).

This page (ASX:BDA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners